title: Is tissue-type plasminogen activator a neuromodulator?
abstract: In the last few years, it has been evidenced that serine proteases play key roles in the mammalian brain, both in physiological and pathological conditions. It has been well established that among these serine proteases, the tissue-type plasminogen activator (t-PA) is critically involved in development, plasticity, and pathology of the nervous system. However, its mechanism of action remains to be further investigated. By using pharmacological and immunological approaches, we have evidenced in the present work that t-PA should be considered as a neuromodulator. Indeed, we have observed that: (i). neuronal depolarization induces a release of t-PA; (ii). this release of t-PA is sensitive to exocytosis inhibition and calcium chelation; (iii). released t-PA modulates NMDA receptor signaling and (iv). astrocytes are able to recapture extracellular t-PA through a low-density lipoprotein (LDL) receptor-related protein (LRP)-dependent mechanism.
authors.affiliation: University of Caen, CNRS, 14047, Caen, France.
authors.forename: Mónica
authors.initials: M
authors.lastname: Fernández-Monreal
authors.forename: José P
authors.initials: JP
authors.lastname: López-Atalaya
authors.forename: Karim
authors.initials: K
authors.lastname: Benchenane
authors.forename: Frederic
authors.initials: F
authors.lastname: Léveillé
authors.forename: Mathias
authors.initials: M
authors.lastname: Cacquevel
authors.forename: Laurent
authors.initials: L
authors.lastname: Plawinski
authors.forename: Eric T
authors.initials: ET
authors.lastname: MacKenzie
authors.forename: Guojun
authors.initials: G
authors.lastname: Bu
authors.forename: Alain
authors.initials: A
authors.lastname: Buisson
authors.forename: Denis
authors.initials: D
authors.lastname: Vivien
mesh_terms: D000200:Action Potentials / Q000187:drug effects / Q000502:physiology; D000818:Animals; D001921:Brain / Q000378:metabolism*; D001923:Brain Chemistry / Q000502:physiology*; D020013:Calcium Signaling / Q000187:drug effects / Q000502:physiology; D002460:Cell Line; D002540:Cerebral Cortex / Q000166:cytology / Q000378:metabolism; D002614:Chelating Agents / Q000494:pharmacology; D005089:Exocytosis / Q000187:drug effects / Q000502:physiology; D005904:Glial Fibrillary Acidic Protein / Q000378:metabolism; D006801:Humans; D026503:Low Density Lipoprotein Receptor-Related Protein-1 / Q000378:metabolism; D051379:Mice; D008869:Microtubule-Associated Proteins / Q000378:metabolism; D016202:N-Methylaspartate / Q000494:pharmacology; D009474:Neurons / Q000187:drug effects / Q000378:metabolism*; D018377:Neurotransmitter Agents / Q000378:metabolism* / Q000494:pharmacology; D016194:Receptors, N-Methyl-D-Aspartate / Q000819:agonists / Q000378:metabolism; D009435:Synaptic Transmission / Q000187:drug effects / Q000502:physiology; D010959:Tissue Plasminogen Activator / Q000378:metabolism* / Q000494:pharmacology
chemical_list: D002614:Chelating Agents; D005904:Glial Fibrillary Acidic Protein; D026503:Low Density Lipoprotein Receptor-Related Protein-1; D008869:Microtubule-Associated Proteins; D018377:Neurotransmitter Agents; D016194:Receptors, N-Methyl-D-Aspartate; D016202:N-Methylaspartate; D010959:Tissue Plasminogen Activator